Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones - PubMed (original) (raw)
Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones
R Manetti et al. J Exp Med. 1994.
Abstract
Interleukin 12 (IL-12) facilitates the generation of a T helper type 1 (Th1) response, with high interferon gamma (IFN-gamma) production, while inhibiting the generation of IL-4-producing Th2 cells in polyclonal cultures of both human and murine T cells and in vivo in the mouse. In this study, we analyzed the effect of IL-12, present during cloning of human T cells, on the cytokine profile of the clones. The culture system used allows growth of clones from virtually every T cell, and thus excludes the possibility that selection of precommitted Th cell precursors plays a role in determining characteristics of the clones. IL-12 present during the cloning procedures endowed both CD4+ and CD8+ clones with the ability to produce IFN-gamma at levels severalfold higher than those observed in clones generated in the absence of IL-12. This priming was stable because the high levels of IFN-gamma production were maintained when the clones were cultured in the absence of IL-12 for 11 d. The CD4+ and some of the CD8+ clones produced variable amounts of IL-4. Unlike IFN-gamma, IL-4 production was not significantly different in clones generated in the presence or absence of IL-12. These data suggest that IL-12 primes the clone progenitors, inducing their differentiation to high IFN-gamma-producing clones. The suppression of IL-4-producing cells observed in polyclonally generated T cells in vivo and in vitro in the presence of IL-12 is not observed in this clonal model, suggesting that the suppression depends more on positive selection of non-IL-4-producing cells than on differentiation of individual clones. However, antigen-specific established Th2 clones that were unable to produce IFN-gamma with any other inducer did produce IFN-gamma at low but significant levels when stimulated with IL-12 in combination with specific antigen or insoluble anti-CD3 antibodies. This induction of IFN-gamma gene expression was transient, because culture of the established clones with IL-12 for up to 1 wk did not convert them into IFN-gamma producers when stimulated in the absence of IL-12. These results suggest that Th clones respond to IL-12 treatment either with a stable priming for IFN-gamma production or with only a transient low level expression of the IFN-gamma gene, depending on their stage of differentiation.
Similar articles
- Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10.
Gerosa F, Paganin C, Peritt D, Paiola F, Scupoli MT, Aste-Amezaga M, Frank I, Trinchieri G. Gerosa F, et al. J Exp Med. 1996 Jun 1;183(6):2559-69. doi: 10.1084/jem.183.6.2559. J Exp Med. 1996. PMID: 8676077 Free PMC article. - B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation.
Murphy EE, Terres G, Macatonia SE, Hsieh CS, Mattson J, Lanier L, Wysocka M, Trinchieri G, Murphy K, O'Garra A. Murphy EE, et al. J Exp Med. 1994 Jul 1;180(1):223-31. doi: 10.1084/jem.180.1.223. J Exp Med. 1994. PMID: 7516409 Free PMC article. - Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones.
Paliard X, de Waal Malefijt R, Yssel H, Blanchard D, Chrétien I, Abrams J, de Vries J, Spits H. Paliard X, et al. J Immunol. 1988 Aug 1;141(3):849-55. J Immunol. 1988. PMID: 2969394 - Acquisition of lymphokine-producing phenotype by CD4+ T cells.
Seder RA, Paul WE. Seder RA, et al. Annu Rev Immunol. 1994;12:635-73. doi: 10.1146/annurev.iy.12.040194.003223. Annu Rev Immunol. 1994. PMID: 7912089 Review. - Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy.
Del Prete G. Del Prete G. Allergy. 1992 Oct;47(5):450-5. doi: 10.1111/j.1398-9995.1992.tb00662.x. Allergy. 1992. PMID: 1485646 Review.
Cited by
- Single nucleotide polymorphisms in the development of osteomyelitis and prosthetic joint infection: a narrative review.
Zhou JQ, Liu ZX, Zhong HF, Liu GQ, Ding MC, Zhang Y, Yu B, Jiang N. Zhou JQ, et al. Front Immunol. 2024 Sep 5;15:1444469. doi: 10.3389/fimmu.2024.1444469. eCollection 2024. Front Immunol. 2024. PMID: 39301021 Free PMC article. Review. - Cancer immunotherapy with enveloped self-amplifying mRNA CARG-2020 that modulates IL-12, IL-17 and PD-L1 pathways to prevent tumor recurrence.
Chen J, Madina BR, Ahmadi E, Yarovinsky TO, Krady MM, Meehan EV, Wang IC, Ye X, Pitmon E, Ma XY, Almassian B, Nakaar V, Wang K. Chen J, et al. Acta Pharm Sin B. 2024 Jan;14(1):335-349. doi: 10.1016/j.apsb.2023.08.034. Epub 2023 Sep 9. Acta Pharm Sin B. 2024. PMID: 38261838 Free PMC article. - Synergistic Effect of Ginsenoside Rh2 Combines with Ionizing Radiation on CT26/luc Colon Carcinoma Cells and Tumor-Bearing Animal Model.
Lee SC, Shen CY, Wang WH, Lee YP, Liang KW, Chou YH, Tyan YS, Hwang JJ. Lee SC, et al. Pharmaceuticals (Basel). 2023 Aug 22;16(9):1188. doi: 10.3390/ph16091188. Pharmaceuticals (Basel). 2023. PMID: 37764996 Free PMC article. - Borrelia burgdorferi Is a Poor Inducer of Gamma Interferon: Amplification Induced by Interleukin-12.
van de Schoor FR, Vrijmoeth HD, Brouwer MAE, Ter Hofstede HJM, Lemmers HLM, Dijkstra H, Boahen CK, Oosting M, Kullberg BJ, Hovius JW, van den Wijngaard CC, van de Veerdonk FL, Netea MG, Joosten LAB. van de Schoor FR, et al. Infect Immun. 2022 Mar 17;90(3):e0055821. doi: 10.1128/iai.00558-21. Epub 2022 Feb 7. Infect Immun. 2022. PMID: 35130450 Free PMC article. - Cytokine Profiling of End Stage Cancer Patients Treated with Immunotherapy.
Merlano MC, Abbona A, Paccagnella M, Falletta A, Granetto C, Ricci V, Fea E, Denaro N, Ruatta F, Merlotti A, Bertetto O, Crosetto N, Galizia D, Basiricò M, Gammaitoni L, Sangiolo D, Aglietta M, Garrone O. Merlano MC, et al. Vaccines (Basel). 2021 Mar 8;9(3):235. doi: 10.3390/vaccines9030235. Vaccines (Basel). 2021. PMID: 33800511 Free PMC article.
References
- Immunol Today. 1991 Nov;12(11):392-5 - PubMed
- J Immunol. 1991 Nov 1;147(9):3149-55 - PubMed
- J Immunol. 1992 Apr 1;148(7):2142-7 - PubMed
- Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6065-9 - PubMed
- Eur J Immunol. 1992 Aug;22(8):2173-6 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials